NEW YORK, NY (Newswire.com)—TARA Biosystems, Inc. today reported in vivo and in vitro functional data from a study of investigational candidate, MYK-491, showing that TARA’s human iPSC-derived organ-on-a-chip technology can directly measure in vivo cardiac performance. These data will be presented today at the American Heart Association’s Scientific Sessions in Philadelphia. MYK-491 is MyoKardia, Inc.’s …
TARA presents at WuXi Healthcare Forum in Shanghai
March 5, 2019
TARA presents today at the WuXi Healthcare Forum in Shanghai. The forum brings together 1000+ innovators, entrepreneurs, clinicians, and investors from around the world that are shaping the future of healthcare.